Skip to content

Impact of chair suryanamaskara on individuals with high blood pressure patients

Effect of chair suryanamaskara on autonomic variables among hypertensive individuals - A randomized control trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096128
Enrollment
50
Registered
2025-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Chair Suryanamaskara: The participants will recieve 6 rounds of chair suryanamaskara , twice a day for a period of 10 days. Each round of chair suryanamaskara contains 12 postures. Cont

Sponsors

Dr.Vishwas S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: the age group of 35 to 60 years. Both male and female subjects will be included in the study. Subjects who are already diagnosed as hypertensive. Subjects who are under medication and non-medication. Those who are willing to participate in the study by signing an informed consent.

Exclusion criteria

Exclusion criteria: Presence of any neurological disorders or any other co-morbidity. Pregnancy or Lactation period. Subjects with other complications such as post trauma/ surgery will be excluded from the study. Women during menstruation. Subject with increased glycemic profile, history of stroke, current abnormal thyroid function, chronic renal failure and psychological conditions.

Design outcomes

Primary

MeasureTime frame
1. Heart Rate Variability (HRV) 2. Blood PressureTimepoint: Pre (baseline),Post (10th day)

Secondary

MeasureTime frame
NIlTimepoint: Nil

Countries

India

Contacts

Public ContactDr Bindu Shridhar

SDM College of Naturopathy and Yogic Sciences, Ujire

smgvish@gmail.com8971316854

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026